AFG
BMY icon

Allegheny Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Allegheny Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Sell
8,665
-29
-0.3% -$1.67K 0.05% 173
2026
Q1 		$527K Buy
8,694
+1,082
+14% +$63.1K 0.07% 151
2025
Q4 		$411K Buy
7,612
+40
+0.5% +$1.92K 0.06% 171
2025
Q3 		$342K Sell
7,572
-226
-3% -$10.6K 0.06% 181
2025
Q2 		$361K Sell
7,798
-95
-1% -$4.66K 0.08% 166
2025
Q1 		$481K Sell
7,893
-832
-10% -$48.5K 0.12% 131
2024
Q4 		$494K Sell
8,725
-10,386
-54% -$580K 0.13% 125
2024
Q3 		$989K Buy
19,111
+11
+0.1% +$516 0.24% 75
2024
Q2 		$793K Sell
19,100
-434
-2% -$19.4K 0.23% 87
2024
Q1 		$1.06M Buy
19,534
+12
+0.1% +$611 0.33% 57
2023
Q4 		$1M Buy
19,522
+797
+4% +$41.8K 0.32% 59
2023
Q3 		$1.09M Buy
18,725
+1,805
+11% +$111K 0.41% 45
2023
Q2 		$1.08M Sell
16,920
-1,683
-9% -$113K 0.51% 33
2023
Q1 		$1.29M Buy
18,603
+6
+0% +$423 0.52% 34
2022
Q4 		$1.34M Buy
18,597
+110
+0.6% +$8.29K 0.56% 34
2022
Q3 		$1.31M Buy
18,487
+293
+2% +$21.3K 0.62% 31
2022
Q2 		$1.4M Sell
18,194
-65
-0.4% -$4.95K 0.65% 32
2022
Q1 		$1.33M Sell
18,259
-323
-2% -$21.7K 0.56% 36
2021
Q4 		$1.16M Buy
18,582
+404
+2% +$23.7K 0.46% 39
2021
Q3 		$1.08M Buy
18,178
+130
+0.7% +$8.56K 0.49% 37
2021
Q2 		$1.21M Sell
18,048
-461
-2% -$30.1K 0.55% 34
2021
Q1 		$1.17M Buy
18,509
+5
+0% +$311 0.85% 20
2020
Q4 		$1.15M Buy
+18,504
New +$1.14M 0.62% 31

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allegheny Financial Group's BMY Position: Q2 2026 in Review

Allegheny Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 0.33% in Q2 2026, selling an estimated $1.67K and leaving 8,665 shares worth $499K. The position accounts for 0.05% of the portfolio, ranked #173.

Allegheny Financial Group first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.4M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Allegheny Financial Group held 8,665 shares of Bristol-Myers Squibb worth $499K as of Q2 2026.
  • Allegheny Financial Group sold 29 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.67K.
  • Bristol-Myers Squibb made up 0.05% of Allegheny Financial Group's portfolio in Q2 2026, its #173 holding.
  • Allegheny Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Allegheny Financial Group's Bristol-Myers Squibb position peaked at $1.4M in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.